All Insights
Showing 1 - 12 of 46
Life Sciences and Healthcare
New WTO Covid-19 vaccine IP waiver proposed
A new vaccine IP waiver proposal has been published by the WTO Director-General following informal negotiations between the EU, India
Life Sciences and Healthcare
Italy is finally poised to get a law on transparency in the healthcare sector
Sunshine Act will oblige Italian pharmas to respect the obligations of transparency regardless of industry codes The Italian Parliament is
Life Sciences and Healthcare
The transfer of Data of non-profit clinical trials to pharmaceutical companies is now allowed in Italy
Previous restrictions on data transfer are lifted, enabling more investment - some clarification on practical issues is awaited In the
Intellectual property
European Commission proposes harmonisation of patent law with unitary SPCs and single procedure for grant
The European Commission has launched a call for evidence on its proposal to create a unitary supplementary protection certificate and/or
Life Sciences and Healthcare
Farmindustria releases updated Code Of Ethics
Italy's association for pharmaceutical companies has amended its Code of Ethics with 4 new articles on PSP and on the
Life Sciences and Healthcare
Is Italy's new law on rare diseases a starting or end point?
Pharmaceutical companies will need to take note of new rules that include funding for research and tax incentives After a
Life Sciences and Healthcare
2021 Life Sciences Patent Case Review
The UK Patents court has had an active year – we review 18 of the principal cases for the sector
Life Sciences and Healthcare
Medical device advertising in Italy: is authorisation by the Ministry of Health still required?
Italian Ministry of Health departs from harmonised EU regulatory framework on advertising medical devices by continuing authorisation regime
Life Sciences and Healthcare
2022 Finance Act increases State investment in Italian national health system
Pharmaceutical spending ceilings are increased and reforms to technical standards are expected
Life Sciences and Healthcare
Global healthcare's embrace of patient support programmes spurs regulatory action
Support programmes for patients are proliferating and regulators are looking to intervene in their international development
Life Sciences and Healthcare
Are European advertising laws ready for patient support programmes?
The legal situation in Europe regarding advertisement of PSPs is highly fragmented with different jurisdictions taking varying approaches to address
